NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for GLENMARK is Neutral → (mild move); technical trend down-trend; trading at ₹2,192.00 (-0.36% today); neutral (RSI 43).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | Down-trend (since 2026-07-22) |
| Price | ₹2,192.00 |
| Change today | -0.36% |
| RSI (14) | 42.90 |
| Relative volume | 0.08 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹65,431 Cr |
| P/E | 36.34 |
| Cap category | Large Cap |
| 52-week high | -9.3% away |
| 52-week low | +21.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for GLENMARK (Glenmark Pharmaceuticals Limited) is Neutral with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
GLENMARK's RSI is neutral (RSI 43). A reading above 70 is typically overbought and below 30 oversold.
GLENMARK is trading about 9% below its 52-week high and 21% above its 52-week low as of Aug 14 2026, 6:50 PM.
GLENMARK's market capitalisation is ₹65,431 Cr as of Aug 14 2026, 6:50 PM.
GLENMARK is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.